San Francisco, California

Senior Director, Evidence Generation & Scientific Communications, Aimmune Theraputics
Represented: Industry

Sarah Donelson is a senior leader with experience in healthcare delivery organizations and the pharmaceutical industry. Her degree in biological anthropology is from New York University, and she has had extensive additional training in statistics and public health at the Harvard School of Public Health and at Johns Hopkins Bloomberg School of Public Health.

She is passionate about understanding patients’ perspectives, quantifying their experiences, and demonstrating outcomes to improve the healthcare system through evidence-based decision-making. She developed and led the global Patient-Reported Outcomes team at Roche, where her innovative work in measuring what matters to asthma patients led her to receive the Roche Innovation Award. She was a founding member of the Critical Path Institute Patient-Reported Outcome Consortium and the Industry Working Group of the International Society for Quality of Life Research. Sarah has been the senior scientist for numerous instrument development projects, health services research programs, and studies investigating emerging technology’s ability to quantify the patient experience.

Donelson served as a member of the Advisory Panel on Patient Engagement from September 2018 to September 2021.

Conflicts of Interest

As of March 27, 2018

  • Genentech, Employer, Stock
  • San Francisco Waldorf School, Volunteer
  • International Society for Pharmacoeconomic and Outcomes Research, Member, Volunteer
  • International Society for Quality of Life Research, Member, Volunteer
  • Academy Health, Member, Volunteer
  • American Society of Clinical Oncology, Member
  • PeaceHealth, Volunteer, Parent


Person Type